THE APEX TIMES
Brian Niccol told Yahoo Finance at the 2026 Invest conference that new wellness-focused beverages are on the way, as Starbucks continues efforts to stabilize demand and execution after recent performance pressure.
Starbucks is preparing additional menu innovation tied to health and wellness, according to comments from CEO Brian Niccol at Yahoo Finance’s 2026 Invest conference. Speaking with Yahoo Finance Executive Editor Brian Sozzi, Niccol said the company is planning collagen drinks and framed the launch as part of Starbucks’ broader push to refresh its beverage mix and improve customer pull.
The CEO’s remarks focused on Starbucks’ ongoing turnaround strategy, an effort that has been centered on changing what customers can order and when, while also sharpening execution across stores. In the interview, Niccol pointed to continued product development and described the pipeline of new items as an important lever for the company’s next phase.
One specific point of emphasis in the discussion was timing, with Niccol referencing Starbucks’ “post-noon” approach. While Starbucks has previously used time-of-day product positioning to shape demand patterns, Niccol’s comments in the Yahoo Finance segment linked that kind of merchandising thinking to the next generation of beverages Starbucks intends to roll out.
Niccol also used the occasion to announcement how Starbucks intends to market the new wellness product category. The interview title, “You’ll definitely glow,” reflects the CEO’s upbeat tone about collagen drinks, though the post does not provide details on flavor profiles, exact launch windows, pricing, or whether the offering would be limited to particular regions or store types.
For Starbucks, wellness-oriented beverages are a logical complement to the chain’s long-running beverages-and-food strategy, particularly as competitors continue to broaden their menu toward “better for you” items. Collagen, specifically, has become a common ingredient theme in the broader consumer packaged beverage market, and the company’s decision to explore it suggests Starbucks is trying to capture incremental occasions beyond coffee-only routines.
The company also appears to be positioning its product strategy as a durability play. In the interview, Niccol connected collagen drinks to a wider turnaround narrative, implying that menu innovation is meant to support both near-term demand and longer-term brand relevance. However, the Yahoo Finance segment does not disclose performance targets, internal metrics, or specific milestones tied to the new items.
Investors and analysts will likely watch for more concrete information on timing and scope. Starbucks has not, in the materials available here, given a launch date, a named product line, or a clear list of countries where collagen drinks will first appear. It is also unclear whether the company plans a single limited-time rollout or a broader permanent addition to the menu.
Next, shareholders will want to see whether Starbucks pairs new wellness products with measurable improvements in sales trends and store-level execution. Any subsequent official announcements, such as menu rollout dates, marketing campaigns, or quarterly commentary that quantifies the impact of “post-noon” merchandising and beverage refreshes, would help confirm whether the collagen launch is translating into sustained momentum.
In an interview at Yahoo Finance’s 2026 Invest conference, Niccol outlined how Starbucks plans to improve speed, appeal, and execution through drive-thru changes alongside menu innovation.
The coffee chain is testing new nutrition-forward items as it looks for incremental traffic during traditionally slower dayparts.
The warehouse retailer is indicating deeper investment in artificial intelligence operations in India, citing a large productivity lift and hinting at broader expansion beyond Hyderabad.
A Wall Street note ahead of Costco’s next earnings read-through suggests stability could be within reach, even as forecasts appear unusually demanding.
A model portfolio spread across Clorox, Kimberly-Clark and PepsiCo estimates annual cash dividends of roughly $67,627. The post also highlights how quickly that income can shrink if any one holding cuts its dividend.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...